Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Model	Intervention
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000012	peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000017	peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000024	peak area	Alzheimer’s disease model	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000032	peak area	Wild type	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000038	peak area	Alzheimer’s disease model	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000043	peak area	Alzheimer’s disease model	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000050	peak area	Alzheimer’s disease model	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1	0.000057	peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1		peak area	Alzheimer’s disease model	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1		peak area	Alzheimer’s disease model	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1		peak area	Wild type	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-1		peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00042	peak area	Alzheimer’s disease model	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00042	peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00045	peak area	Alzheimer’s disease model	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00055	peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00064	peak area	Wild type	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00070	peak area	Wild type	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00071	peak area	Alzheimer’s disease model	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00071	peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00074	peak area	Alzheimer’s disease model	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00075	peak area	Wild type	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00076	peak area	Alzheimer’s disease model	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00085	peak area	Wild type	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00095	peak area	Wild type	Saline
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.00097	peak area	Alzheimer’s disease model	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2	0.0010	peak area	Alzheimer’s disease model	B. breve MCC1274
Reversed phase UNSPECIFIED ION MODE	2-Arachidonoylglycerol-2		peak area	Alzheimer’s disease model	B. breve MCC1274